bf/NASDAQ:XFOR_icon.jpeg

NASDAQ:XFOR

X4 Pharmaceuticals

  • Stock

USD

Last Close

0.69

30/08 20:00

Market Cap

103.11M

Beta: 0.25

Volume Today

726.85K

Avg: 1.81M

PE Ratio

−1.27

PFCF: −1.65

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.10
-
0.02
-
cash per share
7.28
-
3.27
55.10%
223.47
6,732.96%
67.00
70.02%
10.94
83.67%
3.92
64.18%
3.18
18.98%
1.92
39.68%
0.00
99.97%
company equity multiplier
-0.28
-
-0.13
51.48%
1.38
1,129.53%
1.67
20.43%
1.24
25.39%
1.69
35.72%
1.82
7.78%
2.10
15.50%
2.88
37.16%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
298.15
-
111.57
-
dividend yield
1.74
-
0.16
-
ebit per revenue
-13.11
-
-19.96
-
ebt per ebit
0.89
-
0.94
5.84%
0.94
0.65%
0.94
0.00%
1.02
8.93%
1.04
1.36%
1.04
0.65%
1.07
2.84%
0.94
12.26%
effective tax rate
-0.03
-
-0.11
281.46%
-0.06
51.63%
-0.09
64.53%
-0.07
20.74%
-0.00
96.68%
-0.00
91.97%
-0.00
55.65%
-0.00
158.59%
enterprise value multiple
-6.36
-
-4.19
34.08%
1.19
128.46%
0.39
66.99%
-0.46
216.26%
-1.48
224.07%
-0.26
82.57%
0.23
188.24%
-1.39K
607,547.62%
fixed asset turnover
12.28
-
0.33
-
free cash flow per share
-11.84
-
-23.40
97.63%
-81.23
247.18%
-89.19
9.80%
-4.18
95.31%
-3.00
28.34%
-2.78
7.34%
-1.22
56.25%
-0.00
99.96%
gross profit margin
1
-
1
-
interest coverage
-31.41
-
-9.68
69.18%
-17.38
79.54%
-44.16
154.10%
-24.08
45.47%
-22.27
7.50%
-23.37
4.91%
-21.93
6.15%
18.61
184.87%
inventory turnover
long term debt to capitalization
-0.16
-
-0.22
37.32%
0.17
179.09%
0.27
55.18%
0.15
45.61%
0.34
134.22%
0.37
8.67%
0.33
11.87%
0.53
61.72%
net income per ebt
1
-
1
0%
1
0%
1
0%
1.07
7.19%
1.00
6.49%
1.00
0.22%
1.00
0.01%
1.00
0.05%
net profit margin
-12.29
-
-20.71
-
operating cash flow per share
-11.66
-
-23.32
100.06%
-81.10
247.83%
-89.11
9.87%
-4.17
95.32%
-2.93
29.71%
-2.75
6.00%
-1.21
55.92%
-0.00
99.96%
operating profit margin
-13.11
-
-19.96
-
payables turnover
pretax profit margin
-12.29
-
-20.66
-
price fair value
-2.28
-
-1.38
39.32%
0.45
132.45%
0.30
33.99%
0.95
222.76%
1.77
85.74%
0.92
48.38%
0.85
6.94%
2.92K
342,417.74%
receivables turnover
1.22
-
3.27
-
return on assets
-1.39
-
-3.02
117.38%
-0.42
86.20%
-1.19
186.60%
-0.35
70.52%
-0.51
43.56%
-0.76
49.69%
-0.60
20.30%
-0.69
13.87%
return on capital employed
-5.23
-
5.46
204.41%
-0.49
108.99%
-1.50
205.27%
-0.34
77.20%
-0.54
57.91%
-0.83
52.85%
-0.66
20.35%
-0.86
31.54%
return on equity
0.39
-
0.41
5.47%
-0.58
242.06%
-1.99
245.15%
-0.44
78.01%
-0.85
94.83%
-1.38
61.34%
-1.27
7.95%
-1.98
56.19%
total debt to capitalization
-0.27
-
-0.37
39.69%
0.20
153.62%
0.27
34.76%
0.15
43.73%
0.35
129.47%
0.38
10.48%
0.34
10.54%
0.53
55.98%

All numbers in USD (except ratios and percentages)